Changes in ankle brachial index in symptomatic and asymptomatic subjects in the general population

Journal of Vascular Surgery

Volumn 38, Issue 6, 2003, Pages 1323-1330

  Smith, Felicity B ^a   Lee, Amanda J ^b   Price, Jacqueline F ^a   Van Wijk, Marlene C W ^a   Fowkes, F Gerald R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANKLE; ANKLE BRACHIAL INDEX; ARM; ARTICLE; ATHEROSCLEROSIS; COHORT ANALYSIS; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; LEG; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM;

EID: 0345167815     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(03)01021-8     Document Type: Article

References (32)

1. Bernstein EF, Fronek A. Current status of non-invasive tests in the diagnosis of peripheral arterial disease. Surg Clin North Am 1982;62:475-87.
2. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-6.
3. Ogren M, Hedblad B, Isacsson S-O, Janzon L, Jungquist G, Lindell S-E. Non-invasively detected carotid stenosis and ischaemic heart disease in men with leg arteriosclerosis. Lancet 1993;342:1138-41.
4. Kornitzer M, Dramaix M, Sobolski J, Degre S, DeBacker G. Ankle/arm pressure index in asymptomatic middle-aged males: an independent predictor of ten-year coronary heart disease mortality. Angiology 1995;46:211-9.
5. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999;19:538-45.
6. Leng GC, Fowkes FGR, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. Br Med J 1996;313:440-4.
7. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al, for the Cardiovascular Health Study (CHS) Collaborative Research Group. Ankle-arm index as a market of atherosclerosis in the Cardiovascular Health Study. Circulation 1993;88:837-45.
8. Bots ML, Hofman A, Grobbee DE. Common carotid intima-media thickness and lower extremity arterial atherosclerosis: the Rotterdam Study. Arterioscler Thromb 1994;14:1885-91.
9. Allan PL, Mowbray PI, Lee AJ, Fowkes FGR. Relationship between carotid intima-media thickness and symptomatic and asymptomatic peripheral arterial disease: the Edinburgh Artery Study. Stroke 1997;28:348-53.
10. Dormandy JA, Murray GD. The fate of the claudicant - a prospective study of 1969 claudicants. Eur J Vasc Surg 1991;5:131-3.
11. Jelnes R, Gaardsting O, Hougaard Jensen K, Backgaard N, Tonnesen KH, Schroeder T. Fate in intermittent claudication: outcome and risk factors. Br Med J 1986;293:1137-40.
12. Smith I, Franks PJ, Greenhalgh RM, Poulter NK, Powell JT. The influence of smoking cessation and hypertriglycerdaemia on the progression of peripheral arterial disease and the onset of critical ischaemia. Eur J Vasc Endovasc Surg 1996;11:402-8.
13. McLafferty RB, Moneta GL, Taylor LM, Porter JM. Ability of ankle-brachial index to detect lower-extremity atherosclerotic disease progression. Arch Surg 1997;132:836-41.
14. Bird CE, Criqui MH, Fronek A, Denenberg JO, Klauber MR, Langer RD. Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing. Vasc Med 1999;4:15-21.
15. Aquino R, Johnnides C, Makaroun M, Whittle JC, Muluk VS, Kelley ME, et al. Natural history of claudication: long-term serial follow-up study of 1244 claudicants. J Vasc Surg 2001;34:962-70.
16. Nicoloff AD, Taylor LM Jr, Sexton GJ, Schuff RA, Edwards JM, Yeager RA, et al, for the Homocysteine and Progression of Atherosclerosis Study Investigators. Relationship between site of initial symptoms and subsequent progression of disease in a prospective study of atherosclerosis progression in patients receiving long-term treatment for symptomatic peripheral arterial disease. J Vasc Surg 2002;35:38-46.
17. Fowkes FGR, Housley E, Cawood EHH, MacIntyre CCA, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-91.
18. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO 1962;27:645-58.
19. Princas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings: standards and procedures for measurement and classification. London: John Wright; 1982.
20. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. International criteria for acute MI and stroke. Am Heart J 1984;108:150-8.
21. Leng GC, Lee AJ, Fowkes FGR, Whiteman M, Dunbar J, Housley E, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996;25:1172-81.
22. Fowkes FGR, Housley E, MacIntyre CCA, Prescott RJ, Ruckley CV. Variability of ankle and brachial systolic pressures in the measurement of atherosclerotic peripheral arterial disease. Epidemiol Commun Health 1988;42:128-33.
23. Stoffers HEJH, Rinkens PELM, Kester ADM, Kaiser V, Knottnerus JA. The prevalence of asymptomatic and unrecognised peripheral arterial occlusive disease. Int J Epidemiol 1996;25:282-90.
24. Meijer WT, Hoes AW, Rutgers D, Bots ML, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly. The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998;18:185-92.
25. Zheng Z-J, Sharrett AR, Chambless LE, Rosamond WD, Nieto FJ, Sheps DS, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 1997;131:15-25.
26. Abbott RD, Petrovitch H, Rodriguez BL, Yano K, Schatz IJ, Popper JS, et al. Ankle/brachial blood pressure in men > 70 years and the risk of coronary heart disease. Am J Cardiol 2000;86:280-4.
27. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation 1995;91:1472-9.
28. Kaiser V, Kester ADM, Stoffers HEJH, Kitslaar PJEHM, Knottnerus JA. The influence of experience on the reproducibility of the ankle brachial systolic pressure ratio in peripheral arterial occlusive disease. Eur J Vasc Endovasc Surg 1999;18:25-9.
29. Gofin R, Kark JD, Friedlander Y, Lewis BS, Witt H, Stein Y, et al. Peripheral vascular disease in a middle-aged population sample. The Jerusalem Lipid Research Clinic Prevalence Study. Isr J Med Sci 1987;23:157-67.
30. Whyman MR. Natural history of femoral atheromatous lesions. In: Fowkes FGR, editor. Epidemiology of peripheral vascular disease. London: Springer-Verlag; 1991. p. 301-13.
31. Walsh DB, Gilbertson JJ, Zwolak RM, Besso S, Edelman GC, Schneider JR, et al. The natural history of superficial femoral artery stenoses. J Vasc Surg 1991;14:299-304.
32. Fisher CM, Burnett A, Makeham V, Kidd J, Glasson M, Harris JP. Variation in measurement of ankle-brachial pressure index in routine medical practice. J Vasc Surg 1996;24:871-5.